|
Bioconnex Capital Region Commercialization of Life Sciences Innovation Day
June 1, 2012
More>>
News
St. Peter’s Hospital seeks new CEO
AMRI appoints pharmaceutical executive to board
Albany Med, Ellis join new health IT investment program
CDPHP gives Albany Med $1.4 million gift
Regeneron reports new drug cuts cholesterol levels nearly in half
Glens Falls Hospital raising $2M to buy radiation therapy technology
NYC scientists win $500,000 Albany Medical Center Prize
Biotech conference scheduled for June 1
Bioconnex Announces Capital Region Commercialization of Life Sciences Innovation Day
Bio-based manufacturers stand to gain from proposed legislation
HVCC construction zone: $35 million Science Center rising
Rensselaer Biologists Uncover Surprising Connection Between Breast Cancer Cells and Surrounding Tissue
AMRI Expands Quality Control Leadership to Support Future Growth
Taconic turns 60!
Patenting antibodies: You get what you ask for, or do you?
Regeneron and Bayer Announce Approval of EYLEA® (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
BIO Praises House Passage of the Jumpstart Our Business Startups Act
Anatomy of the $360M Albany Med expansion
Resources & Funding
IP Portfolio Management Strategies for Medical Device Manufacturers
Stem Cell Research
|
|
Full Events Calendar
MayOrigins of CD4+ Memory T Cells Presented by: Albany Medical College
May 21, 2012 Regulation in cis and trans Controls B Cell Receptor Endocytosis via Select Tyrosine-based Motifs Presented by: Albany Medical College
May 22, 2012 Hypertension in Children: Why Get All Worked Up About It Presented by: Albany Medical College
May 23, 2012 Biomolecular Tools for Sustainable Energy and Improved Human Health Presented by: RPI
May 23, 2012 Functional Genomic Studies of Breast Cancer, and Revealing the Transcriptome Using Next-Generation Presented by: University at Albany
May 23, 2012
|
